Neuromodulation Market (Spinal Cord Stimulation, Vagus Nerve Stimulation, Gastric Electrical Stimulation) Worth $6.8 Billion by 2017 - New Report by MarketsandMarkets

This report estimates the Neuromodulation market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others (http://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html).

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
MarketsandMarkets

MarketsandMarkets

Key Players - Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Enteromedics, Inc (U.S.), Neuropace, Inc (U.S.), Zynex, Inc (U.S.) and Neuronetics, Inc (U.S.)

(PRWEB) April 19, 2014

The “Neuromodulation Market – [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] – Forecasts to 2017” analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, APAC, and Rest of the World.

Browse 93 market data tables, 4 figures spread through 193 Pages with an in-depth TOC on “Neuromodulation Market"
http://www.marketsandmarkets.com/Market-Reports/neurostimulation-devices-market-921.html

Early buyers will receive 10% customization on this report.

This report studies the global neuromodulation devices market (2012 to 2017). The 2011 neuromodulation device market is estimated to be $3.9 billion in 2012, predicted to grow at a CAGR of 11.6% to reach $6.8 billion by 2017.

Ask for Free PDF @ http://www.marketsandmarkets.com/pdfdownload.asp?id=921

The global neuromodulation market has been broadly divided into two major segments based on the nature of procedure, namely, invasive or internal neuromodulation and non-invasive or external neuromodulation. The invasive neuromodulation segment comprises of spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric nerve stimulation, whereas the non-invasive technology segment consists of transcranial magnetic stimulation (TMS) and transcutaneous electrical neuromodulation (TENS). All the techniques are further sub-segmented by its various applications.

Inquire Before Buying @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=921

The neuromodulation market is expected to be a high growth market in the coming decade. It consists of devices used to modulate or alter neurons by means of passing electric pulses through the nerves. Notable segments of the neuromodulation market are spinal cord stimulation, deep brain stimulation, and vagus nerve stimulation. Vagus nerve stimulation, being nascent in the market, will represent the maximum growth in the coming years fuelled by its wider scope of application and less invasive nature as compared to other SCS or DBS techniques. The spinal cord stimulation technique holds maximum share in the market, yet, it is observed to have a slower growth.

Research studies and clinical trials also show a promising future for DBS and transcranial magnetic stimulation market in new applications like Alzheimer’s, drug resistant depression, tinnitus, etc. The key factors that drive the neuromodulation market are higher incidences of endemic diseases, rise in aging population, technological advancement, devices under approval, and presence of several niche players. Reimbursement in certain geographies and cost of devices are major challenges faced by this market. North America is estimated to account for the maximum share of the neuromodulation market in 2012, followed by Europe, and Asia-Pacific countries like Japan, India, and China.

Browse Related Reports:
Nerve Repair & Regeneration Market by Xenografts (Conduits, Protectors), Neuromodulation [Internal (Spinal Cord, Deep Brain)], External (Transcranial Magnetic)], Surgery [Direct Nerve Repair, Grafting, Stem Cell] - Global Trend & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/nerve-repair-regeneration-market-883.html

Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017
http://www.marketsandmarkets.com/Market-Reports/bio-implants-market-728.html

bout MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


Contact

Follow us on: Contact's Google Plus